47. Cresta S, Sessa C, Catapano CV, Gallerani E, Passalacqua D, Rinaldi A et al. Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumors. Eur J Cancer 2008; 44: 1829–1834. 48. Croghan GA, Suman VJ, Maples WJ, Albertini M, Linette G, Flaherty L ...
The strategy of clinically targeting cancerous cells at their most vulnerable state during mitosis has instigated numerous studies into the mitotic cell death (MCD) pathway. As the hallmark of cancer revolves around cell-cycle deregulation, it is not sur
As the hallmark of cancer revolves around cell-cycle deregulation, it is not surprising that antimitotic therapies are effective against the abnormal proliferation of transformed cells. Moreover, these antimitotic drugs are also highly selective and sensitive. Despite the robust rate of discovery and ...